Dr Elisabeth Roider is Harvard- and Swiss-trained, internationally renowned physician-scientist with a strong entrepreneurial background. She currently holds a position as an attending and principal investigator at the University Hospital of Basel, Switzerland, and a visiting scientist position at the Harvard Medical School in Boston, USA. Her scientific focus is in the areas of immunology, microbiology, biochemistry, redox biology and cell metabolism. Elisabeth leads a multidisciplinary team including clinicians, basic scientists, machine learning specialists, mathematicians, statisticians, and epidemiologists, allowing a bench-to-bedside approach to solve complex, medical questions in the most efficient way. Her work has resulted in various high-impact publications, patents and awards, including the ground-breaking discovery of a novel mechanism of skin pigmentation.

Driven by the mission to identify and solve the most relevant medical and public health problems, Elisabeth cofounded the Swiss Venture Studio Maximon as a Partner where she serves as a Chief Scientific and Medical Officer. In this role she combines her clinical, scientific and entrepreneurial experience to support scientists and physicians in transforming true innovation into solid solutions and products, helping patients and consumers to achieve a better, healthier and longer life.